Saved in:
| Main Author: | Liangwei Yin (尹良威) |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Online Access: | https://doi.org/10.5281/zenodo.15697455 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Comprehensive analysis of pain genes in prognosis of kidney renal clear cell carcinoma and tumor immunotherapy: A comprehensive bioinformatic study
by: Xiao‐Yu Zhuang, et al.
Published: (2024)
by: Xiao‐Yu Zhuang, et al.
Published: (2024)
Acanthosis Nigricans associated with clear-cell renal cell carcinoma
by: Fernando Peixoto Ferraz de Campos
Published: (2016)
by: Fernando Peixoto Ferraz de Campos
Published: (2016)
Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma
by: Zhan Yang, et al.
Published: (2024)
by: Zhan Yang, et al.
Published: (2024)
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
by: Wenhao Xu, et al.
Published: (2024)
by: Wenhao Xu, et al.
Published: (2024)
Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma
by: Motohiro Fujiwara, et al.
Published: (2024)
by: Motohiro Fujiwara, et al.
Published: (2024)
Synchronous clear cell renal cell carcinoma and classic Hodgkin lymphoma
by: Phuoc Christie‐Nguyen, et al.
Published: (2025)
by: Phuoc Christie‐Nguyen, et al.
Published: (2025)
Belzutifan's role in the treatment landscape of clear cell renal cell carcinoma
by: Adrienne H. Chen, et al.
Published: (2025)
by: Adrienne H. Chen, et al.
Published: (2025)
Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
by: Bin Zheng, et al.
Published: (2024)
by: Bin Zheng, et al.
Published: (2024)
Differences in mutations across tumour sizes in clear‐cell renal cell carcinoma
by: Steven M. Monda, et al.
Published: (2024)
by: Steven M. Monda, et al.
Published: (2024)
A multimodal deep learning framework for predicting sunitinib response in advanced clear cell renal cell carcinoma
by: Xi Tian, et al.
Published: (2025)
by: Xi Tian, et al.
Published: (2025)
Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study
by: Jian Deng, et al.
Published: (2024)
by: Jian Deng, et al.
Published: (2024)
Multi‐instance learning for identifying high‐risk subregions associated with synchronous distant metastasis in clear cell renal cell carcinoma
by: Ling‐Feng Xue, et al.
Published: (2024)
by: Ling‐Feng Xue, et al.
Published: (2024)
Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment
by: Bo Guan, et al.
Published: (2024)
by: Bo Guan, et al.
Published: (2024)
Role of tertiary lymphoid structures in the tumour microenvironment and immunotherapy response of renal cell carcinoma
by: Lin Yang, et al.
Published: (2025)
by: Lin Yang, et al.
Published: (2025)
Immunogenic cell death–related genes predict prognosis and response to immunotherapy in lung squamous cell carcinoma
by: Guoping Li, et al.
Published: (2024)
by: Guoping Li, et al.
Published: (2024)
Unravelling infiltrating T‐cell heterogeneity in kidney renal clear cell carcinoma: Integrative single‐cell and spatial transcriptomic profiling
by: Haiqing Chen, et al.
Published: (2024)
by: Haiqing Chen, et al.
Published: (2024)
Identifying genes associated with disease outcomes using joint sparse canonical correlation analysis—An application in renal clear cell carcinoma
by: Diptavo Dutta, et al.
Published: (2024)
by: Diptavo Dutta, et al.
Published: (2024)
A multimodal ensemble approach for clear cell renal cell carcinoma treatment outcome prediction
by: Chen, Meixu, et al.
Published: (2024)
by: Chen, Meixu, et al.
Published: (2024)
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma
by: Zhiduan Cai, et al.
Published: (2024)
by: Zhiduan Cai, et al.
Published: (2024)
Comprehensive analyses of nuclear mitochondria‐related genes in the molecular features, immune infiltration, and drug sensitivity of clear cell renal cell carcinoma
by: Yuchen Zhang, et al.
Published: (2024)
by: Yuchen Zhang, et al.
Published: (2024)
CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells
by: Kongjia Wang, et al.
Published: (2024)
by: Kongjia Wang, et al.
Published: (2024)
First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy
by: Takafumi Yanagisawa, et al.
Published: (2024)
by: Takafumi Yanagisawa, et al.
Published: (2024)
Proteomic profiling of ovarian clear cell carcinomas identifies prognostic biomarkers for chemotherapy
by: Liang Yue, et al.
Published: (2024)
by: Liang Yue, et al.
Published: (2024)
Nc‐RNA‐mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma
by: Xinyi Zeng, et al.
Published: (2024)
by: Xinyi Zeng, et al.
Published: (2024)
CRYAB is upregulated and predicts clinical prognosis in kidney renal clear cell carcinoma
by: Hao Ren, et al.
Published: (2025)
by: Hao Ren, et al.
Published: (2025)
Integrative analysis of bulk and single‐cell RNA sequencing reveals sphingolipid metabolism and immune landscape in clear cell renal cell carcinoma
by: Dongdong Xie, et al.
Published: (2024)
by: Dongdong Xie, et al.
Published: (2024)
A single gene mutation predicts response to immune checkpoint blockade in ovarian clear cell carcinoma
by: Matheus Henrique Dias, et al.
Published: (2025)
by: Matheus Henrique Dias, et al.
Published: (2025)
Paraoxonase‐2 shRNA‐mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines
by: Valentina Schiavoni, et al.
Published: (2024)
by: Valentina Schiavoni, et al.
Published: (2024)
Adjuvant immunotherapy for high‐risk renal cell carcinoma—now or never?
by: Tivya Kulasegaran, et al.
Published: (2024)
by: Tivya Kulasegaran, et al.
Published: (2024)
CLEC18A interacts with sulfated glycosaminoglycans and controls clear cell renal cell carcinoma progression
by: Gustav Jonsson, et al.
Published: (2025)
by: Gustav Jonsson, et al.
Published: (2025)
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade
by: Frederik F. Thomsen, et al.
Published: (2024)
by: Frederik F. Thomsen, et al.
Published: (2024)
Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma
by: Yuta Kaneko, et al.
Published: (2024)
by: Yuta Kaneko, et al.
Published: (2024)
Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma
by: Martyna Parol‐Kulczyk, et al.
Published: (2024)
by: Martyna Parol‐Kulczyk, et al.
Published: (2024)
Comprehensive analysis of m6A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma
by: Hexin Li, et al.
Published: (2024)
by: Hexin Li, et al.
Published: (2024)
CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
by: Can Chen, et al.
Published: (2024)
by: Can Chen, et al.
Published: (2024)
A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis
by: Ei Shiomi, et al.
Published: (2024)
by: Ei Shiomi, et al.
Published: (2024)
Tumor‐associated macrophages impair NK cell IFN‐γ production and contribute to tumor progression in clear cell renal cell carcinoma
by: Sol Yanel Núñez, et al.
Published: (2024)
by: Sol Yanel Núñez, et al.
Published: (2024)
Carbonic anhydrase‐9‐targeted near‐infrared photoimmunotherapy as a theranostic modality for clear cell renal cell carcinoma
by: Hiroshi Fukushima, et al.
Published: (2025)
by: Hiroshi Fukushima, et al.
Published: (2025)
Diagnostic value of imaging in patients with clear cell papillary renal cell carcinoma: A case series and literature review
by: Yuxuan Song, et al.
Published: (2024)
by: Yuxuan Song, et al.
Published: (2024)
Papillary renal cell carcinoma with high‐ ABCC2 shows an immune‐evasive profile associated with favorable response to immunotherapy
by: Vincent Francis Castillo, et al.
Published: (2025)
by: Vincent Francis Castillo, et al.
Published: (2025)
Similar Items
-
Comprehensive analysis of pain genes in prognosis of kidney renal clear cell carcinoma and tumor immunotherapy: A comprehensive bioinformatic study
by: Xiao‐Yu Zhuang, et al.
Published: (2024) -
Acanthosis Nigricans associated with clear-cell renal cell carcinoma
by: Fernando Peixoto Ferraz de Campos
Published: (2016) -
Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma
by: Zhan Yang, et al.
Published: (2024) -
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
by: Wenhao Xu, et al.
Published: (2024) -
Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma
by: Motohiro Fujiwara, et al.
Published: (2024)